TP53 and hematologic disorder: In fact, these findings are in line with previous reports in which the antitumor activity of nutlin-3a was demonstrated in a variety of wild-type p53 cancer cells of both solid tumors [10], [11], [15] and hematological malignancies [12], [13], [14].